Mitochondrial impairment observed in fibroblasts from South African Parkinson's disease patients with parkin mutations

Biochemical and Biophysical Research Communications

Volumn 447, Issue 2, 2014, Pages 334-340

  Van Der Merwe, Celia ^a   Loos, Ben ^b   Swart, Chrisna ^a   Kinnear, Craig ^a,b   Henning, Franclo ^a   Van Der Merwe, Lize ^a,c   Pillay, Komala ^d   Muller, Nolan ^a   Zaharie, Dan ^e   Engelbrecht, Lize ^b   Carr, Jonathan ^a   Bardien, Soraya ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c UNIVERSITY OF THE WESTERN CAPE   (South Africa)

^d RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

^e Division of Anatomical Pathology   (South Africa)

Author keywords

Fibroblasts; Mitochondrial dysfunction; Muscle; Parkin mutations; Parkinson's disease

Indexed keywords

ADENOSINE TRIPHOSPHATE; PARKIN;

ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOCHONDRION SWELLING; MUSCLE BIOPSY; MUSCLE CELL; MUTATION; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SARCOLEMMA; SKIN BIOPSY; SOUTH AFRICA; WILD TYPE;

FIBROBLASTS; MITOCHONDRIAL DYSFUNCTION; MUSCLE; PARKIN MUTATIONS; PARKINSON'S DISEASE;

ADENOSINE TRIPHOSPHATE; FIBROBLASTS; HUMANS; MITOCHONDRIA; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MUTATION; PARKINSON DISEASE; SARCOLEMMA; UBIQUITIN-PROTEIN LIGASES;

EID: 84899920605     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.03.151     Document Type: Article

References (25)

1. L.M.L. de Lau, and M.M.B. Breteler Epidemiology of Parkinson's disease Lancet Neurol. 5 2006 525 535 10.1016/S1474-4422(06)70471-9
2. T. Gasser Mendelian forms of Parkinson's disease Biochim. Biophys. Acta 1792 2009 587 596 10.1016/j.bbadis.2008.12.007
3. S. Lubbe, and H.R. Morris Recent advances in Parkinson's disease genetics J. Neurol. 2013 10.1007/s00415-013-7003-2
4. T. Kitada, S. Asakawa, N. Hattori, H. Matsumine, Y. Yamamura, and S. Minoshima et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 1998 605 608 10.1038/33416
5. T.M. Dawson Molecular pathways of neurodegeneration in Parkinson's disease Science 302 2003 819 822 10.1126/science.1087753
6. P.J. Kahle, and C. Haass How does parkin ligate ubiquitin to Parkinson's disease? EMBO Rep. 5 2004 681 685 10.1038/sj.embor.7400188
7. J.C. Greene, A.J. Whitworth, I. Kuo, L.A. Andrews, M.B. Feany, and L.J. Pallanck Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants Proc. Natl. Acad. Sci. U. S. A. 100 2003 4078 4083 10.1073/pnas.0737556100
8. J.J. Palacino Mitochondrial dysfunction and oxidative damage in parkin-deficient mice J. Biol. Chem. 279 2004 18614 18622 10.1074/jbc.M401135200
9. A. Grünewald, L. Voges, A. Rakovic, M. Kasten, H. Vandebona, and C. Hemmelmann et al. Mutant parkin impairs mitochondrial function and morphology in human fibroblasts PLoS One 5 2010 e12962 10.1371/journal.pone.0012962
10. H.-H. Hoepken, S. Gispert, B. Morales, O. Wingerter, D. Del Turco, and A. Mülsch et al. Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6 Neurobiol. Dis. 25 2007 401 411 10.1016/j.nbd.2006.10.007
11. H. Mortiboys, K.J. Thomas, W.J.H. Koopman, S. Klaffke, P. Abou-Sleiman, and S. Olpin et al. Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts Ann. Neurol. 64 2008 555 565 10.1002/ana.21492
12. C. Pacelli, D. De Rasmo, A. Signorile, I. Grattagliano, G. di Tullio, and A. D'Orazio et al. Mitochondrial defect and PGC-1α dysfunction in parkin-associated familial Parkinson's disease Biochim. Biophys. Acta 2011 1812 1041 1053 10.1016/j.bbadis.2010.12.022
13. F.R. Wiedemann, K. Winkler, H. Lins, C.-W. Wallesch, and W.S. Kunz Detection of respiratory chain defects in cultivated skin fibroblasts and skeletal muscle of patients with Parkinson's disease Ann. N. Y. Acad. Sci. 893 1999 426 429 10.1111/j.1749-6632.1999.tb07870.x
14. G. Auburger, M. Klinkenberg, J. Drost, K. Marcus, B. Morales-Gordo, and W.S. Kunz et al. Primary skin fibroblasts as a model of Parkinson's disease Mol. Neurobiol. 46 2012 20 27 10.1007/s12035-012-8245-1
15. M. Müftüoglu, B. Elibol, O. Dalmizrak, A. Ercan, G. Kulaksiz, and H. Ogüs et al. Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations Mov. Disord. Off. J. Mov. Disord. Soc. 19 2004 544 548 10.1002/mds.10695
16. W.R. Gibb, and A.J. Lees The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease J. Neurol. Neurosurg. Psychiatry 51 1988 745 752 10.1136/jnnp.51.6.745
17. S. Bardien, R. Keyser, Y. Yako, D. Lombard, and J. Carr Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease Parkinsonism Relat. Disord. 15 2009 116 121 10.1016/j.parkreldis.2008. 04.005
18. W.L. Haylett, R.J. Keyser, M.C. du Plessis, C. van der Merwe, J. Blanckenberg, and D. Lombard et al. Mutations in the parkin gene are a minor cause of Parkinson's disease in the South African population Parkinsonism Relat. Disord. 18 2012 89 92 10.1016/j.parkreldis.2011.09.022
19. R.J. Keyser, D. Lombard, R. Veikondis, J. Carr, and S. Bardien Analysis of exon dosage using MLPA in South African Parkinson's disease patients Neurogenetics 11 2010 305 312 10.1007/s10048-009-0229-6
20. J.P. (S version), D.B. (up to 2007), S.D. (up to 2002), D.S. (up to 2005), E. authors, R-core, nlme: Linear and Nonlinear Mixed Effects Models, 2013.
21. A. Sandebring, N. Dehvari, M. Perez-Manso, K.J. Thomas, E. Karpilovski, and M.R. Cookson et al. Parkin deficiency disrupts calcium homeostasis by modulating phospholipase C signalling FEBS J. 276 2009 5041 5052 10.1111/j.1742-4658.2009.07201.x
22. A. Grünewald, M.E. Gegg, J.-W. Taanman, R.H. King, N. Kock, and C. Klein et al. Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology Exp. Neurol. 219 2009 266 273 10.1016/j.expneurol.2009.05.027
23. K. Verhoeven, K.G. Claeys, S. Züchner, J.M. Schröder, J. Weis, and C. Ceuterick et al. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2 Brain J. Neurol. 129 2006 2093 2102 10.1093/brain/awl126
24. H.A. Hanagasi, P. Serdaroglu, M. Ozansoy, N. Basak, H. Tasli, and M. Emre Mitochondrial pathology in muscle of a patient with a novel parkin mutation Int. J. Neurosci. 119 2009 1572 1583
25. Y. Imaizumi, Y. Okada, W. Akamatsu, M. Koike, N. Kuzumaki, and H. Hayakawa et al. Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue Mol. Brain 5 2012 35 10.1186/1756-6606-5-35